1.AydemirO., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265.2.Bessis A., Bechade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007; 55: 233-238.3.Brody A.L., Saxena S., Mandelken M.A. et al. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001; 50: 171-178.4.Brook O.H., van Hout H.P.J., Stalman W.A.B., de Haan M. Nontricylic antidepressants: predictors of nonadherence. J Clin Psychopharmacol 2006; 26: 643-647.5.Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4: 215-222.6.Colla M., Kronenberg G., Deuschle M. et al. Hippocampal volume reduction and HPA-system activity in major depression. J Psychiat Res 2007; 41: 553-560.7.Davidson R.J. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003; 40: 655-665.8.de Kloet E.R., Derijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralcorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 2007; 3:168-179.9.Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition, Text-Revision. Washington, DC: American Psychiatric Press 2000.10.Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49: 341-361.11.Duman R.S. Neurotrophic factors and regulation of mood: role of exercise, diet, and metabolism. Neurobiol Aging 2005; 6: Suppl: 88-93.12.Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54: 597-606.13.Duman R.S., Monteggia L.M. A neurotrophic model for stress related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.14.Duric V., McCarson K.E. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 2005; 6: 999-1006.15.Fava M., Mallinckrodt C.H., Detke M.J. et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates. J Clin Psychiatry 2004; 65: 521-530.16.Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007; 21: 47-59.